Background: Butyrylcholinesterase deficiency can result in prolonged paralysis after administration of succinylcholine or mivacurium. We conducted an interview study to assess whether patients with butyrylcholinesterase deficiency were more likely to have experienced awareness during emergence from anaesthesia if neuromuscular monitoring had not been applied. Methods: Patients referred during 2004-2012 were included. Data on the use of neuromuscular monitoring were available from a previous study. Interviews, conducted by telephone, included questions about awareness and screening for post-traumatic stress disorder. Reports of panic, hopelessness, suffocation, or a feeling of being dead or dying resulted in the experience being classified further as distressful. Patients were categorized as aware or unaware by investigators blinded to use of neuromuscular monitoring. Results: Ninety-five patients were eligible to be interviewed. Of the 70 patients interviewed, 35 (50%) were aware while paralysed during emergence. Of these, 28 (80%) were not monitored with a nerve stimulator when awakened, compared with 17 (49%) of the 35 unaware patients (P=0.012, Fisher's exact test). Thirty (86%) aware patients reported distress compared with seven (20%) unaware patients (P<0.001). The aware patients scored higher in screening for post-traumatic stress disorder (P=0.006, Mann-Whitney U-test). Conclusions: Butyrylcholinesterase deficiency is a major risk factor for distressing awareness during emergence. Lack of neuromuscular monitoring increases the risk significantly. Neuromuscular monitoring should be applied even when using short-acting neuromuscular blocking agents.
The recently published 5th National Audit Project (NAP5) on accidental awareness in general anaesthesia revealed that the experience of emerging from anaesthesia with residual neuromuscular block was interpreted by many patients as anaesthesia awareness. 5 Failure to monitor the degree of neuromuscular block with a nerve stimulator was judged causal or contributory in the majority of these instances. The Danish Cholinesterase Research Unit (DCRU) receives referrals of patients suspected of BChE deficiency. 6 In a DCRU registry study (Thomsen and colleagues), 7 we found that application of neuromuscular monitoring was associated with lower risk of premature awakening in patients suspected of BChE deficiency. However, it has never been investigated whether patients with BChE deficiency are genuinely at increased risk of awareness. In the present interview study, we investigated whether patients suspected of BChE deficiency were more likely to have experienced awareness during emergence from anaesthesia if they were not monitored with a nerve stimulator.
Methods
The Committees on Health Research Ethics in Denmark confirmed that the study could be initiated without approval (H-4-2013-164).
The Danish Data Protection Agency (HEH-2014-003/02597) approved the study. The DCRU is a clinical database registered with the Danish Data Protection Agency.
Eligibility
We included patients referred to the DCRU from January 2004 to May 2012. Data on the use of neuromuscular monitoring were available from an earlier study. In that study, two groups were defined: patients monitored with a nerve stimulator from the beginning of anaesthesia (monitored group), and patients not monitored at all (unmonitored group). Patients for whom a nerve stimulator was applied only when residual neuromuscular block was suspected were also included in the unmonitored group because this was considered inappropriate use of neuromuscular monitoring. Patients were excluded from the present study if they were <18 yr old at the time of the interview, <15 yr old at the time of the procedure leading to referral to the DCRU, or were unable to complete the interview because of mental impairment, non-Danish speaking, or death. Patients who declined participation or who could not be contacted were also excluded.
Interviews
We designed an interview guide consisting of multiple choice and open-ended questions related to the perioperative experience ( Table 1 ). The interview guide was based on experiences reported in studies of awareness in anaesthesia. [8] [9] [10] A modified
Brice interview was included to differentiate between intraoperative awareness and awareness during emergence from anaesthesia. 11 As anaesthesia awareness can lead to post-traumatic stress disorder (PTSD), 13 we also included the PTSD checklist specific version (PCL-S) 12 to screen for long-term psychological sequelae.
The checklist consists of 17 items in four categories of PTSD symptoms: re-experiencing, avoidance, numbing, and hyperarousal. Each item is scored from 1 'not at all' to 5 'extremely', resulting in a total score between 17 and 85. We chose a cut-off value of 44 as indicative of possible PTSD as proposed by Blanchard and colleagues. 14 The choice of cut-off value of the PCL-S has an effect on the specificity and the sensitivity of the test as a screening tool for PTSD. Also, the optimal cut-off value can be found only when the true prevalence of PTSD in the population is known. 15 Patients were asked to participate in the interview study by letter. A reminder was sent to non-responders after 2 months. Three investigators (J.L.T., K.Z.E., and M.N.D.) conducted the interviews by telephone. Before this, the investigators discussed the interview guide extensively to ensure that interviews were conducted in the same manner. To reduce interviewer bias, the investigators were blinded to all clinical information except the following: the indication for the procedure, hospital, date of surgery, and the patient's age at the time of the procedure. Patients were informed that the purpose of the study was to describe their perioperative experience, but not about the intended examination of the association between neuromuscular monitoring and awareness during emergence from anaesthesia. Replies were typed directly in an electronic form containing the interview guide. Patients reporting psychological sequelae were advised to contact their general practitioner.
Assessment and classification
Two investigators (J.L.T. and M.R.G.) reviewed the responses to assess whether the patients had been aware while paralysed during emergence from anaesthesia. Patients reporting actual paralysis, e.g. inability to open their eyes, move, breathe, or speak while still in the operating room (OR), were classified as aware.
Patients with an uneventful emergence from anaesthesia and no report of paralysis constituted the unaware group. Patients reporting 'feeling heavy', but not paralysed, or for whom it could not be determined if the reported incident took place in the OR or in the intensive care unit (ICU) were classified as 'possible', and were included in the aware group. Patients who had experienced paralysis after leaving the OR (i.e. in the ICU) were classified as paralysed in the ICU. Hence, a patient could be classified as unaware (in the OR), but paralysed in the ICU. Finally, the assessors judged whether the postoperative experience as a whole was described as distressing, according to the Michigan awareness scale. 16 Among others, reports of panic, hopelessness, suffocation, or a feeling of being dead or dying (Table 1 ) resulted in the experience being classified as distressful. Disagreements were settled by discussion. The assessors were blinded to clinical data (i.e. the use of neuromuscular monitoring).
Outcomes
The primary outcome was awareness during emergence from anaesthesia. Secondary outcomes were paralysis in the ICU, experience reported as distressing, and total PCL-S score. Patients with pre-existing anxiety, depression, or PTSD were excluded from the analysis of the PCL-S score.
Statistical analysis
Categorical data were compared using Fisher's exact test. The correlation between use of neuromuscular monitoring and awareness during emergence from anaesthesia was calculated using logistic regression and reported as odds ratio with 95% confidence interval (CI). Possible confounders were tested for statistical significance and, if found significant, included in the analysis, giving an adjusted odds ratio. The PCL-S scores were compared using the Mann-Whitney U-test. Analyses were done in SPSS (version 19.0; SPSS Inc., Chicago, IL, USA) and R (version 3.1.0; R Foundation for Statistical Computing, Vienna, Austria).
A value of P<0.05 was considered statistically significant. 
Results
A total of 127 patients were eligible, including the 123 patients analysed in the companion paper. 7 An additional four patients who were excluded from the other study because of missing information of the primary outcome were also included. Of 95 -patients eligible for interview, contact could not be obtained in 24 instances and one patient declined to participate, resulting in 70 interviewed patients (Fig. 1 ). Interviews were conducted from December 2012 to March 2013. Patient characteristics and perioperative data for the aware and unaware groups are shown in Table 2 . The duration of interview was mean 29 min (range 13-68) and 22 min (range 10-46) in the aware and unaware group, respectively. Interviews were conducted with the aware and unaware patients 4 yr (range 1-9) and 5 yr (range 1-9) after the anaesthesia event that led to referral to the DCRU. The cause for BChE deficiency was homozygous mutations in the butyrylcholinesterase (BCHE) gene in 51 (73%) patients and heterozygous mutations in 10 (14%) patients (Table 2 ). Five (7%) patients had a normal genotype with medication or conditions that decrease BChE activity, while four (6%) had a normal genotype with non-BChE-related explanations for the events that led to referral.
Awareness during emergence from anaesthesia and paralysis in the intensive care unit
A total of 31 (44%) of the 70 patients interviewed had experienced awareness during emergence from anaesthesia. An additional four patients (6%) were classified as 'possible' and were included in the aware group. Of the 35 patients in the aware group, 28 (80%) were not monitored with a nerve stimulator when anaesthesia was terminated, compared with 17 (49%) of 35 in the unaware group (P=0.012). Neuromuscular monitoring reduced the risk of awareness during emergence from anaesthesia [odds ratio 0.24 (95% CI 0.08-0.68), P=0.008]. Possible confounders tested for significance included the following: sex, ASA physical status, age, neuromuscular blocking agent administered (succinylcholine vs mivacurium or combinations), genotype (homozygous mutations vs others), and time since the procedure. Only age proved statistically significant [odds ratio 0.97 (95% CI 0.94-0.998), P=0.036] and was included in the analysis, resulting in an adjusted odds ratio of 0.23 (95% CI 0.08-0.68; P=0.008).
Upon completion of the study, we grouped patients according to reported experience, use of neuromuscular monitoring, and cause of prolonged neuromuscular block. Patients representative of these groups are reported in Table 3 . Six (17%) patients in the aware group also reported being paralysed in the ICU after leaving the OR (Table 3 , section B). Of the unaware patients, nine (26%) reported being paralysed in the ICU, but did not recall anything from the OR (Table 3 , section C). The unaware patients In the following, 17 problems and complaints that people sometimes have in response to stressful life experiences will be mentioned. In this case, the stressful experience refers to the procedure and anaesthetic. Please listen to each one carefully, and then give your answer to indicate how much you have been bothered by that problem in the past month. For each question, please choose the bestsuiting answer: not at all, a little bit, moderately, quite a bit, and extremely. In the past month, to which degree have you been bothered by:
1. Repeated, disturbing memories, thoughts, or images of the stressful experience? 2. Repeated, disturbing dreams of the stressful experience? 3. Suddenly acting or feeling as if the stressful experience were happening again (as if you were reliving it)? 4. Feeling very upset when something reminded you of the stressful experience? 5. Having physical reactions (e.g. heart pounding, trouble breathing, sweating) when something reminded you of the stressful experience? 6. Avoiding thinking about or talking about the stressful experience or avoiding having feelings related to it? 7. Avoiding activities or situations-including avoiding anaesthesia or going to the hospital-because they reminded you of the stressful experience? 8. Were any of the five lastly mentioned problems present before the stressful experience? Remark: each item is scored as 1 (not at all), 2 (a little bit), 3 (moderately), 4 (quite a bit), or 5 (extremely). A total symptom severity score (range=17-85) is obtained by summing the scores from each of the 17 items.
Concluding questions
Did you receive any kind of professional counselling because of your experience? Did you suffer from any diagnosed psychiatric illness before the experienced event or have you been diagnosed after the experience? Do you have any supplementary information that you find relevant for this study?
typically remembered nothing at all from the OR ( Table 3 , sections D and G). Seven patients experienced awareness during emergence from anaesthesia despite the use of neuromuscular monitoring (Table 3 , section F). In five of these patients, neuromuscular monitoring was applied but apparently malfunctioning, or results were disregarded. In the remaining two patients, no problems with the nerve stimulator were reported in the anaesthesia records. While patients homozygous for BCHE mutations accounted for the most distressing instances of awareness during emergence from anaesthesia, six patients with heterozygous mutations or normal genotype with acquired BChE deficiency also reported being paralysed in the OR (Table 2 and  Table 3 , sections H and I).
Distress
The experience was assessed to be distressing in 30 (86%) of the aware patients and seven (20%) of the unaware patients (P<0.001). Of the five patients in the aware group reporting no distress, two had experienced the event as in a dream, one was halfasleep when realizing he was paralysed, one was conscious for only a very short time, and one described how the anaesthesia personnel calmly explained that the paralysis was only temporary (Table 3 , section E). Of the seven unaware patients reporting distress, six had experienced paralysis in the ICU, explaining their distress (Table 3 , section C).
Screening for post-traumatic stress disorder
In screening for PTSD, three patients were excluded because of a psychiatric condition diagnosed before the procedure: two with PTSD (one in the aware group, PCL-S score 62, one in the unaware group, PCL-S score 56) and one with anxiety and depression (unaware group, PCL-S score 72). This information was revealed at the end of the interview ( Table 1 ). The median PCL-S scores in the 34 aware and 33 unaware patients were 19 (range 17-51) and 17 (range 17-35), respectively (P=0.023). One patient in the aware group had a PCL-S score of 51, indicating possible PTSD (Table 3 , patient 2).
Discussion
Our study revealed that 50% of patients referred to the DCRU because of suspected BChE deficiency had experienced awareness during emergence from anaesthesia, thereby establishing BChE deficiency as a major risk factor for awareness. Aware patients were not monitored with a nerve stimulator in 80% of instances, or neuromuscular monitoring was applied only when BChE deficiency was suspected, which was after a failed attempt to awaken the patient. Furthermore, patients who had experienced awareness during emergence from anaesthesia scored higher in screening for PTSD. To our knowledge, no study has examined the subjective experience of patients with BChE deficiency systematically. Numerous case reports describe patients with prolonged neuromuscular block from succinylcholine or mivacurium. In some of these, patients may have been conscious while paralysed, 3 17 18 but the patient's own experience is rarely described. Combining data from the DCRU with structured interviews provided a unique opportunity to describe the point of view of patients with BChE deficiency. Our study showed that patients either homozygous or heterozygous for BCHE mutations can experience postoperative paralysis, resulting in awareness. Homozygosity of the clinically most important BCHE mutation (the atypical variant A) occurs with a frequency of one in 3000 in Caucasians and results in prolonged duration of action of 2-3 h after succinylcholine 1 mg kg −1 i.v. However, one in five people carry the most common lowactivity variant, the K-variant. 19 Patients heterozygous or homozygous for the K-variant have 30% prolonged neuromuscular block, 20 which can also be clinically relevant for short procedures, such as electroconvulsive therapy or reduction of hip dislocation. 21 This indicates that awareness during emergence from anaesthesia could be a common but underreported problem. As in NAP5, 22 many patients in the present study found it very distressing suddenly to be awake while paralysed; some even believed that they were dead or dying. Others felt no distress because they were confident that the paralysis was only temporary. Likewise, Pilgram and colleagues 4 reported on a patient who experienced no fear or helplessness because she had faith in the anaesthesiologist, who kept her calm through the 30 min that passed before neuromuscular monitoring was applied and the condition was recognized. Also, completely paralysed well-informed volunteers reported no distress as long as they were not hypercapnic. 23 Unlike the patients in our study, the volunteers had practised the procedure beforehand and were even able to communicate through hand gestures, probably making it much less traumatic. Our findings support that informing and calming a patient who is unexpectedly conscious while paralysed is important to prevent distress.
Paralysis in the intensive care unit
Some patients were conscious while paralysed, not only at the primary awakening attempt in the OR, but also when transferred to the ICU, after BChE deficiency was suspected. They may have been insufficiently sedated after BChE deficiency was recognized, or they may have been awakened a second time after arrival to the ICU before regaining full neuromuscular function. Most patients receiving intensive care are only sedated lightly. In contrast, patients with newly recognized BChE deficiency may be completely paralysed for hours without being able to communicate or understand the situation. This emphasizes the importance of sufficient sedation until neuromuscular function has fully recovered.
Long-term psychological consequences
Awareness has not been described systematically in patients with BChE deficiency before, nor have its long-term psychological consequences. Intraoperative awareness is reported to result in PTSD in 0-71% of cases. 12 We screened one patient positive for PTSD in the aware group and none in the unaware group. However, our study is too small to draw any conclusions about the true incidence of PTSD in this population. Our finding of a small but statistically significant difference of two points in PCL-S total score between patients with and without neuromuscular monitoring may be of questionable clinical significance in itself. Even so, awareness during emergence from anaesthesia must be considered a serious complication to anaesthesia based on the primary outcome alone. Future studies may reveal whether patients with BChE deficiency are indeed at risk of developing PTSD if aware while paralysed.
Significance of neuromuscular monitoring
Many of the distressing experiences reported could have been avoided by careful application of quantitative neuromuscular monitoring before awakening, reassuring the patient if awakened prematurely, and by sufficient sedation until full recovery of neuromuscular function. Experts in the field have recommended the use of quantitative neuromuscular monitoring whenever a non-depolarizing neuromuscular blocking agent is administered. 24 25 This recommendation should be applied to all neuromuscular blocking agents, including succinylcholine, because the BChE activity of an individual patient is rarely known before the procedure. In order to enable anaesthetists to comply with such recommendations, there is a need for education in neuromuscular monitoring and rational management of the neuromuscular block.
Limitations
The study has some limitations. The questionnaire developed was not validated, although the PCL-S screening instrument has been validated in Norwegian, a language very similar to Danish. 26 Furthermore, the PCL-S should be used cautiously when screening is not followed by a more thorough and time-consuming standardized diagnostic interview. 15 The questionnaire could have been tested on a group of surgical patients without BChE deficiency, in order to determine the contribution of BChE deficiency to the postoperative experience. The delay between procedure and interview may have caused underreporting of awareness during emergence from anaesthesia, perhaps especially in patients without distress. The assessors of the experiences are not experts in awareness. However, in contrast to intraoperative awareness, the assessor did not judge the authenticity of the reported experiences as is done when assessing intraoperative awareness, but merely if paralysis was reported. The 25 patients who were eligible but could not be interviewed may have affected our results. Acknowledging these limitations, we believe that our findings are relevant, not only to patients with BChE deficiency, but also to any patient receiving a neuromuscular blocking agent.
Conclusion
In conclusion, we found that 50% of patients suspected of BChE deficiency had experienced awareness during emergence from anaesthesia. Neuromuscular monitoring was not applied before awakening in the majority of aware patients, and it seems to be the tool for preventing awareness during emergence from anaesthesia. Hence, neuromuscular monitoring should be applied even when using short-acting BCHE-metabolized neuromuscular blocking agents.
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